Damage Detection and Localization on Real Structures Subjected to Strong Motion Earthquakes Using the Curvature Evolution Method: The Navelli (Italy) Case Study

In recent years, structural health monitoring (SHM) has received increasing interest from both research and professional engineering communities. This is due to the limitations related to the use of traditional methods based on visual inspection for a rapid and effective assessment of structures and infrastructures when compared with the great potential offered by newly developed automatic systems. Most of these kinds of systems allow the continuous estimation of structural modal properties that are strictly correlated to the mechanical characteristics of the monitored structure. These can change as a result of material deterioration and structural damage related to earthquake shaking. Furthermore, a suitable configuration of a dense sensor network in a real-time monitoring system can allow to detect and localize structural and non-structural damage by comparing the initial and a final state of the structure after a critical event, such as a relevant earthquake. In this paper, the modal curvature evaluation method, used for damage detection and localization on framed structures, considering the mode curvature variation due to strong earthquake shaking, is further developed. The modified approach is validated by numerical and experimental case studies. The extended procedure, named "Curvature Evolution Method" (CEM), reduces the required computing time and the uncertainties in the results. Furthermore, in this work, an empirical relationship between curvature variation and damage index has been defined for both bare and infilled frames

A Cell-Based Small Molecule Screening Method for Identifying Inhibitors of Epithelial-Mesenchymal Transition in Carcinoma

Epithelial Mesenchymal Transition (EMT) is a crucial mechanism for carcinoma progression, as it provides routes for in situ carcinoma cells to dissociate and become motile, leading to localized invasion and metastatic spread. Targeting EMT therefore represents an important therapeutic strategy for cancer treatment. The discovery of oncogene addiction in sustaining tumor growth has led to the rapid development of targeted therapeutics. Whilst initially optimized as anti-proliferative agents, it is likely that some of these compounds may inhibit EMT initiation or sustenance, since EMT is also modulated by similar signaling pathways that these compounds were designed to target. We have developed a novel screening assay that can lead to the identification of compounds that can inhibit EMT initiated by growth factor signaling. This assay is designed as a high-content screening assay where both cell growth and cell migration can be analyzed simultaneously via time-course imaging in multi-well plates. Using this assay, we have validated several compounds as viable EMT inhibitors. In particular, we have identified compounds targeting ALK5, MEK, and SRC as potent inhibitors that can interfere with EGF, HGF, and IGF-1 induced EMT signaling. Overall, this EMT screening method provides a foundation for improving the therapeutic value of recently developed compounds in advanced stage carcinoma